Carisma Therapeutics Inc (NASDAQ:CARM) has a beta value of 1.86 and has seen 1.33 million shares traded in the recent trading session. The company, currently
Carisma Therapeutics Inc (NASDAQ:CARM)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 1.85. At the close of
In the last trading session, 1.15 million Carisma Therapeutics Inc (NASDAQ:CARM) shares changed hands as the company’s beta touched 1.98. With the company’s per share
Carisma Therapeutics Inc (NASDAQ:CARM) has a beta value of 1.67 and has seen 15.98 million shares traded in the last trading session. The company, currently
During the last session, Carisma Therapeutics Inc (NASDAQ:CARM)’s traded shares were 2.89 million, with the beta value of the company hitting 1.69. At the end
Carisma Therapeutics Inc (NASDAQ:CARM)’s traded shares stood at 36.57 million during the last session, with the company’s beta value hitting 2.04. At the close of
In the latest trading session,, 0.93 million Carisma Therapeutics Inc (NASDAQ:CARM) shares changed hands as the company’s beta touched 1.70. With the company’s most recent
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne